Navigation Links
Antiviral Drugs May Be Useful For Easing Shingles Pain

According to a new study, oral and intravenous antiviral drug may be helpful in easing out shingles-related nerve pain//.

Shingles, which is caused by varicella-zoster virus, is a painful nervous disorder.

Foodconsumer.org reports that researchers at the University of Colorado and Health Sciences Center in Denver gave antiviral treatment to 12 men and three women with moderate to severe pain following shingles. The patients received 10 milligrams of the drug acyclovir intravenously every eight hours for 14 days. They then took three 1,000-milligram pills of the drug valacyclovir per day for one month.

The patients rated their pain on a scale of zero to 10 before they began treatment, then again after completing each therapy, and again one month after completing treatment.

As reported online this week by the journal Archives of Neurology, one month after treatment, eight (53 percent) of the patients reported significant reduction (two or more points) in their pain -- similar to the number of patients who reported similar improvements after day 15 and after day 45.

Five of the patients dropped out of the study early, three of them due to complications caused by the therapy. Most patients tolerated the treatment well, however, the researchers said.

'Although our study was small and without placebo control, the findings suggest a promising effect of antiviral treatment on postherpetic neuralgia [shingles nerve pain],' the study authors concluded.
'"/>




Page: 1

Related medicine news :

1. Roche Commits More Antiviral Pills To Asia For Bird Flu
2. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
3. Antiviral Coating On Bank Notes, Photocopiers Could Help Check Epidemics
4. Antiviral Drugs Curb Influenza Virus
5. Call For Bird Flu Antiviral Drugs To Be Shared
6. New Ribosome Finding Could Lead to Antiviral Therapies
7. Lean Protein Could Be Key to Obesity Drugs
8. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
9. Nasal Spray Could Take Drugs Direct to Brain.
10. Emphasis to ban Drugs ads by Doctors
11. Osteoporosis Drugs: right time to take-off
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... ... software, in partnership with Snowfall4pod Digital, creators of the gContentManager & Distribution ... content management, global distribution and print-on-demand network. , AVALANCHE allows enterprise customers ...
(Date:2/9/2016)... ... 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: BONT), which ... it has raised $176,000 to benefit the Breast Cancer Research Foundation, Froedtert & ... University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic Cancer Center ...
(Date:2/9/2016)... ... 09, 2016 , ... Two renowned photographers, Robert Caplin (New York, NY) and ... island, June 14-19, 2016, hosted by Four Seasons Resort Maui at Wailea as part ... debut in 2015, the Maui Photo Expedition workshop will once again consist ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... has officially been won. A team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ... to preserve the delicate neural circuits of an intact rabbit brain for extremely ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance Agency, serving ... a new charity campaign. As part of their ongoing community involvement program, funds ... belief that children deserve a voice, and in the spirit of neighbors helping ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... 2016 first quarter ended December 31, 2015. ... First Quarter Highlights , Revenue of $36.5 million ... 2015 , Domestic Radiation Measurement services revenues increased 2.8% ...
(Date:2/9/2016)... , February 9, 2016 ... gab heute den Abschluss eines Kooperationsvertrags mit ... umfassender Lösungen in den Bereichen Next-Generation-Sequencing (NGS), ... QGEN ; Frankfurt Prime Standard: QIA) gab ... Genomics für die Entwicklung und Förderung umfassender ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
Breaking Medicine Technology: